Renowned Tobacco Company Raises Prices on Top Brands

Aug.24.2022
Renowned Tobacco Company Raises Prices on Top Brands
Reynolds raises prices of traditional cigarettes, including second-largest US brand Newport, and popular e-cigarette Vuse.

According to analyst Bonnie Herzog of Goldman Sachs, Reynolds Tobacco Company will be increasing the price of its top traditional cigarette brand, Newport, by 17 cents starting on Monday.


Tobacco companies are accelerating the rate of price increases for both their traditional and electronic cigarette brands, despite ongoing inflation pressures on consumers' wallets. Goldman Sachs analyst Bonnie Herzog released a detailed analysis to Reynolds Tobacco investors on Monday, stating that Reynolds' price hikes will take effect on Monday.


In addition to traditional cigarettes, Reynolds Tobacco will also increase the price of Vuse, the best-selling electronic cigarette in the United States.


Traditional cigarette prices have been experiencing slight and frequent increases.


This will be the fourth price increase of the year for Renou tobacco after four price hikes in 2021. It's worth noting that the most recent increase occurred in early July.


Renowned brand Newport, Renault's best-seller, has seen a price increase of 17 cents per pack. Newport is the second largest brand in the US market, behind only Philip Morris' Marlboro. Over the past 10 months, many of Renault's top brands have seen a total price increase of $1.05, with a total increase of $1.62 since January 2020.


Renault has also increased the price per pack of its Eclipse product by 17 cents.


Tobacco manufacturers continue to increase the prices of traditional cigarettes and e-cigarettes, a development that does not surprise Roger Beahm, Executive Director of the Retail Innovation Center at Wake Forest University School of Business. Beahm notes that manufacturers are raising prices frequently and incrementally rather than infrequently and dramatically, which helps minimize the impact of price increases. Despite marketing restrictions and increased awareness of the risks associated with tobacco use, Beahm also highlights the ongoing loyalty of consumers to tobacco brands.


The price of electronic cigarettes continues to rise.


According to Nielsen's monthly analysis of convenience store sales, Vuse has surpassed Juul to become the best-selling electronic cigarette in the United States over the past three months. As for the company's Vuse Alto e-cigarette product, single pod packs will increase by $3.40 per box. Two pod packs will increase by $5.15 per box, and four pod packs will increase by $6.90 per box. Vuse Solopod and Vuse Vibepod will each increase by $7.10 per box. The prices of Vuse Solo and Vuse Vibe motorized cigarette holders will increase by $3.60.


British American Tobacco (BAT) reported in its first half 2022 financial results that sales of its new tobacco products, including Vuse, heated tobacco product glo (not sold in the US), and oral products Camel Snus and Velo, increased revenue by 45.4% to $1.55 billion.


The Chief Executive Officer of British American Tobacco, Jack Bowles, stated in a press release that "we have a robust and resilient product portfolio in the United States, with shares in both combustible tobacco and vape markets increasing continuously.


We are continuing to increase our market share in traditional tobacco and so far, we have not seen an acceleration in the decline of our traditional tobacco product portfolio.


In June, Jain Gaurav, an industry analyst at Barclays, stated that given the challenges faced by all major e-cigarette manufacturers in the US and worldwide, it is important to keep a close eye on whether users will accept the price increase for Vuse.


In recent months, the rising prices of pods have been considered a possible barrier to transitioning traditional smokers to e-cigarettes. Gaurav suggests that the increase in price of e-cigarettes might lead to a shift for British American Tobacco from a loss of 350 million dollars in fiscal year 2021 to a profit of 200 million dollars in fiscal year 2022. Gaurav also predicts that by fiscal year 2025, profits for e-cigarettes could reach 700 million dollars.


Statement:


This article is compiled based on third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS and we are unable to confirm the authenticity and accuracy of its content. The translation of this article is only intended for industry-related communication and research purposes.


Due to limitations in translation capabilities, the translated article may not fully convey the original message. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.


The copyrights of the compiled information belong to the original media and authors. If there is any infringement, please contact for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Product | JTI Philippines Expands Nordic Spirit Nicotine Pouch Portfolio With Dark Pop and Red Frost
Product | JTI Philippines Expands Nordic Spirit Nicotine Pouch Portfolio With Dark Pop and Red Frost
JTI Philippines has expanded the Nordic Spirit nicotine pouch portfolio in the Philippines with two new variants, Dark Pop and Red Frost. Both products maintain the brand’s tobacco-free nicotine pouch positioning, with Dark Pop featuring a fizzy cola profile with citrus and sweet notes, while Red Frost combines cool mint with sweet red berry flavors. The two variants are now available through Philippine online retail channels.
Aug.18
Senate Democrat Wyden Probes Trump Administration Vape Policy Shift, Seeks Records From HHS and Reynolds American
Senate Democrat Wyden Probes Trump Administration Vape Policy Shift, Seeks Records From HHS and Reynolds American
U.S. Senator Ron Wyden, the Democratic ranking member of the Senate Finance Committee, has launched an investigation into flavored vape policy changes and requested records from the Department of Health and Human Services (HHS), Reynolds American and Botanic Tonics. The investigation focuses on a timeline involving Reynolds American’s $5 million donation to MAGA Inc. in April 2026 and subsequent vape policy developments. Wyden said the review aims to examine potential links between political donations, corporate communications and government decisions. The investigation does not represent a finding of wrongdoing.
Innovation
Aug.07 by 2Firsts Perspectives
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
Nicotine Pouches Gain Ground in U.S. Convenience Stores as Vape Unit Sales Fall 14%
Nicotine Pouches Gain Ground in U.S. Convenience Stores as Vape Unit Sales Fall 14%
According to convenience retail publication CStore Decisions, U.S. convenience store tobacco categories are undergoing a structural shift. Based on Circana OmniMarket Total U.S. Convenience data for the 52 weeks ending June 14, 2026, cigarettes remained the largest category with $50.8 billion in sales, but unit sales declined 5.3%. Electronic smoking devices and vaping products also declined, while modern oral nicotine products continued to grow, with nicotine pouch sales rising 29% in dollars and 17% in units. Retailers said changing consumer preferences are reshaping tobacco product assortments at convenience stores.
Regulations
Aug.07